Trigr Therapeutics
Irvine, US · Founded 2018 · Delaware corporation
Founders & leadership
GU
George UyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10M disclosed across 2 rounds · 2018–2019
▶$5MraisedApr 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedApr 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Miranda ToledanoExecutive Officer, Director
- George UyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- Proceeds to insiders
- $150K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$5MraisedApr 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$5MraisedApr 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George UyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $1M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Trigr Therapeutics raised?
- Trigr Therapeutics has disclosed $10M raised across 2 rounds.
- Where is Trigr Therapeutics headquartered?
- Trigr Therapeutics is headquartered in Irvine, US.